A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Astrocytoma
Related studies linked through entity extraction aliases.
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
- Status
- COMPLETED
- Phase
- N/A
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
- Status
- COMPLETED
- Phase
- N/A
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
- Status
- COMPLETED
- Phase
- PHASE2